GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.360 +0.080 (+2.44%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

22 23 Next >

Why GoodRx Surged Today ↗

March 25, 2024

The prescription-drug upstart got an upgrade from Wall Street.

Via The Motley Fool

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says ↗

March 25, 2024

Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.

Via Benzinga

The Latest Analyst Ratings For GoodRx Holdings ↗

March 25, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings ↗

February 26, 2024

Via Benzinga

Unveiling 7 Analyst Insights On GoodRx Holdings ↗

January 02, 2024

Via Benzinga

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 25, 2024

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.

Via Benzinga

Topics Stocks

GoodRx Interim CEO Extends Commitment to Company

March 14, 2024

From GoodRx Holdings, Inc.

Via Business Wire

These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings ↗

March 01, 2024

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates.

Via Benzinga

Why GoodRx Stock Soared Today ↗

February 29, 2024

The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.

Via The Motley Fool

GoodRx (GDRX) Q4 2023 Earnings Call Transcript ↗

February 29, 2024

GDRX earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Why Is Telemedicine Firm GoodRx's Shares Surging Today ↗

February 29, 2024

GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program.

Via Benzinga

GoodRx Reports Fourth Quarter and Full Year 2023 Results

February 29, 2024

From GoodRx Holdings, Inc.

Via Business Wire

This healthcare stock making a buzz with 160% growth

February 26, 2024

Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them.

Via MarketBeat

Topics Economy

GoodRx to Participate in Upcoming Investor Conferences

February 20, 2024

From GoodRx Holdings, Inc.

Via Business Wire

Gene therapy: Why does it cost millions for a single treatment?

February 15, 2024

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.

Via MarketBeat

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

February 01, 2024

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

January 22, 2024

From GoodRx Holdings, Inc.

Via Business Wire

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

January 11, 2024

From GoodRx

Via Business Wire

Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars ↗

January 10, 2024

GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million.

Via Benzinga

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

January 10, 2024

From GoodRx Holdings, Inc.

Via Business Wire

Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up ↗

January 09, 2024

Election stocks include companies at the center of national conversation and those likely to get increased government funding.

Via InvestorPlace

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

GoodRx Appoints Kelly J. Kennedy to Board of Directors

December 22, 2023

From GoodRx

Via Business Wire

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 13, 2023

From GoodRx Holdings, Inc.

Via Business Wire

This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

November 20, 2023

U.S. stocks closed slightly higher on Friday, with the S&P 500 notching gains for the third straight week. The S&P 500 gained 2.2% last week, while the Dow Jones ended the week with a 1.9% gain.

Via Benzinga

Topics Stocks

GoodRx to Participate in the Evercore ISI HealthCONx Conference

November 16, 2023

From GoodRx Holdings, Inc.

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.